Bayer plc

Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA
Telephone: +44 (0)1635 563 000
Fax: +44 (0)1635 563 393
WWW: http://www.bayer.co.uk

Patient Information Leaflet last updated on the eMC: 03/11/2009
PIL Noristerat

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/11/2009 and displayed until Current
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 11/06/2008 and displayed until 03/11/2009
Reasons for adding or updating:
  • Change to MA holder contact details
  • Change to date of revision
  • Change of licence holder
  • Change to Marketing Authorisation Holder
Updated on 26/08/2004 and displayed until 11/06/2008
Reasons for adding or updating:
  • Change of active ingredient
  • Change to date of revision
Updated on 17/03/2004 and displayed until 26/08/2004
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 03/07/2000 and displayed until 17/03/2004
Reasons for adding or updating:
  • No reasons supplied
Updated on 03/02/2000 and displayed until 03/07/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   norethisterone enantate